HC Wainwright Raises Verastem (NASDAQ:VSTM) Price Target to $10.00
Verastem (NASDAQ:VSTM – Get Free Report) had its target price upped by analysts at HC Wainwright from $7.00 to $10.00 in a report released on Monday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 52.21% from the stock’s previous […]
Verastem (NASDAQ:VSTM – Get Free Report) had its target price upped by analysts at HC Wainwright from $7.00 to $10.00 in a report released on Monday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 52.21% from the stock’s previous […]
